GERARD J. VLAK, PH.D.

Corporate Board Profile

Tech Score: 0/100

GT Biopharma, Inc.

Filing Date	Source Excerpt
2004-04-29	Gerard J. Vlak, Ph.D. Age: 70 Director. Dr. Vlak was appointed to the Board of Directors as part of the Understanding described above in the section of this Proxy Statement entitled Change In Control. ... After the resignations of Messrs. Wolf and Pryor, the Board of Directors appointed Mr. Neill and Gerard J. Vlak, Ph.D. as new members of this Committee, such that the Committee is currently comprised of Mr. Davis (Chair), Mr. Neill and Dr. Vlak.

Filing Date

Source Excerpt

2004-04-29

Gerard J. Vlak, Ph.D. Age: 70 Director. Dr. Vlak was appointed to the Board of Directors as part of the Understanding described above in the section of this Proxy Statement entitled Change In Control. ... After the resignations of Messrs. Wolf and Pryor, the Board of Directors appointed Mr. Neill and Gerard J. Vlak, Ph.D. as new members of this Committee, such that the Committee is currently comprised of Mr. Davis (Chair), Mr. Neill and Dr. Vlak.

Data sourced from SEC filings. Last updated: 2025-08-30